Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

The Effectiveness and Value of Biologic Therapies for the Treatment of Uncontrolled Asthma.

Tice JA, Campbell JD, Synnott PG, Walsh JME, Kumar VM, Whittington M, Adair E, Rind D, Pearson SD.

J Manag Care Spec Pharm. 2019 May;25(5):510-514. doi: 10.18553/jmcp.2019.25.5.510.

2.

"I'm scared": Journaling Uncovers Student Perceptions Prior to a Psychiatric Clinical Rotation.

Wedgeworth ML, Ford CD, Tice JR.

J Am Psychiatr Nurses Assoc. 2019 Apr 15:1078390319844002. doi: 10.1177/1078390319844002. [Epub ahead of print]

PMID:
30983470
3.

A response to "Personalised medicine and population health: breast and ovarian cancer".

Antoniou A, Anton-Culver H, Borowsky A, Broeders M, Brooks J, Chiarelli A, Chiquette J, Cuzick J, Delaloge S, Devilee P, Dorval M, Easton D, Eisen A, Eklund M, Eloy L, Esserman L, Garcia-Closas M, Goldgar D, Hall P, Knoppers BM, Kraft P, La Croix A, Madalensky L, Mavaddat N, Mittman N, Nabi H, Olopade O, Pashayan N, Schmidt M, Shieh Y, Simard J, Stover-Fiscallini A, Tice JA, Van't Veer L, Wenger N, Wolfson M, Yau C, Ziv E.

Hum Genet. 2019 Mar;138(3):287-289. doi: 10.1007/s00439-019-01984-z. Epub 2019 Feb 27. No abstract available.

4.

Validation of the breast cancer surveillance consortium model of breast cancer risk.

Tice JA, Bissell MCS, Miglioretti DL, Gard CC, Rauscher GH, Dabbous FM, Kerlikowske K.

Breast Cancer Res Treat. 2019 Jun;175(2):519-523. doi: 10.1007/s10549-019-05167-2. Epub 2019 Feb 22.

PMID:
30796654
5.

Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma.

Whittington MD, McQueen RB, Ollendorf DA, Kumar VM, Chapman RH, Tice JA, Pearson SD, Campbell JD.

JAMA Netw Open. 2019 Feb 1;2(2):e190035. doi: 10.1001/jamanetworkopen.2019.0035.

6.

Clinician accountability in a primary care clinic time-interval blood pressure measurements study: Practice implications.

Tice JR, Cole LG, Ungvary SM, George SD, Oliver JS.

Appl Nurs Res. 2019 Feb;45:69-72. doi: 10.1016/j.apnr.2018.12.006. Epub 2018 Dec 12.

PMID:
30683255
7.

Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia.

Whittington MD, McQueen RB, Ollendorf DA, Kumar VM, Chapman RH, Tice JA, Pearson SD, Campbell JD.

JAMA Pediatr. 2018 Dec 1;172(12):1161-1168. doi: 10.1001/jamapediatrics.2018.2530.

8.

An Intervention Tool to Increase Patient-Physician Discussion of Lifestyle Risk Factors for Breast Cancer.

Ozanne E, Karliner LS, Tice JA, Haas JS, Livaudais-Toman J, Pasick RJ, Kaplan CP.

J Womens Health (Larchmt). 2019 Nov;28(11):1468-1475. doi: 10.1089/jwh.2018.7026. Epub 2018 Sep 15.

PMID:
30222505
9.

Disease-Modifying Therapies for Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis.

Zimmermann M, Brouwer E, Tice JA, Seidner M, Loos AM, Liu S, Chapman RH, Kumar V, Carlson JJ.

CNS Drugs. 2018 Dec;32(12):1145-1157. doi: 10.1007/s40263-018-0566-9.

PMID:
30141001
10.

Zero-static power radio-frequency switches based on MoS2 atomristors.

Kim M, Ge R, Wu X, Lan X, Tice J, Lee JC, Akinwande D.

Nat Commun. 2018 Jun 28;9(1):2524. doi: 10.1038/s41467-018-04934-x.

11.

Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort.

Braithwaite D, Miglioretti DL, Zhu W, Demb J, Trentham-Dietz A, Sprague B, Tice JA, Onega T, Henderson LM, Buist DSM, Ziv E, Walter LC, Kerlikowske K; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2018 Apr 1;178(4):494-501. doi: 10.1001/jamainternmed.2017.8642.

12.

Integrated nanomaterials for extreme thermal management: a perspective for aerospace applications.

Barako MT, Gambin V, Tice J.

Nanotechnology. 2018 Apr 2;29(15):154003. doi: 10.1088/1361-6528/aaabe1.

PMID:
29384132
13.

Dense Vertically Aligned Copper Nanowire Composites as High Performance Thermal Interface Materials.

Barako MT, Isaacson SG, Lian F, Pop E, Dauskardt RH, Goodson KE, Tice J.

ACS Appl Mater Interfaces. 2017 Dec 6;9(48):42067-42074. doi: 10.1021/acsami.7b12313. Epub 2017 Nov 20.

PMID:
29119783
14.

Atomically Thin Femtojoule Memristive Device.

Zhao H, Dong Z, Tian H, DiMarzi D, Han MG, Zhang L, Yan X, Liu F, Shen L, Han SJ, Cronin S, Wu W, Tice J, Guo J, Wang H.

Adv Mater. 2017 Dec;29(47). doi: 10.1002/adma.201703232. Epub 2017 Oct 25.

PMID:
29067743
15.

ASGE EndoVators Summit: Defining the role and value of endoscopic therapies in obesity management.

ASGE EndoVators Task Force, Ryou M, McQuaid KR, Thompson CC, Edmundowicz S, Mergener K, Abu Dayyeh B, Apovian C, Burke C, Chand B, Chandraker A, Deas T, Dietz W, Dunkin B, Ernest O, Faigel D, Garber S, Hamdy O, Kaplan L, Kumar N, Kushner R, Larsen MC, Lerner H, Littenberg G, Mantzoros C, Mattar S, Moore R, Rinella M, Rothstein R, Schillinger D, Spring B, Sullivan S, Tice J, Vargo J, Wilson E, Woods K, Zundel N.

Gastrointest Endosc. 2017 Nov;86(5):757-767. doi: 10.1016/j.gie.2017.08.004. Epub 2017 Oct 12. No abstract available.

PMID:
29031371
16.

ASGE EndoVators Summit: Defining the role and value of endoscopic therapies in obesity management.

Ryou M, McQuaid KR, Thompson CC, Edmundowicz S, Mergener K, Dayyeh BA, Apovian C, Burke C, Chand B, Chandraker A, Deas T, Dietz W, Dunkin B, Ernest O, Faigel D, Garber S, Hamdy O, Kaplan L, Kumar N, Kushner R, Larsen MC, Lerner H, Littenberg G, Mantzoros C, Mattar S, Moore R, Rinella M, Rothstein R, Schillinger D, Spring B, Sullivan S, Tice J, Vargo J, Wilson E, Woods K, Zundel N.

Surg Obes Relat Dis. 2017 Nov;13(11):1805-1816. doi: 10.1016/j.soard.2017.08.024. Epub 2017 Sep 8. No abstract available.

PMID:
29030161
17.

Microscale Liquid Transport in Polycrystalline Inverse Opals across Grain Boundaries.

Pham QN, Barako MT, Tice J, Won Y.

Sci Rep. 2017 Sep 5;7(1):10465. doi: 10.1038/s41598-017-10791-3.

18.

Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial.

Kazi DS, Penko J, Coxson PG, Moran AE, Ollendorf DA, Tice JA, Bibbins-Domingo K.

JAMA. 2017 Aug 22;318(8):748-750. doi: 10.1001/jama.2017.9924. No abstract available.

19.

Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones.

Shieh Y, Hu D, Ma L, Huntsman S, Gard CC, Leung JWT, Tice JA, Ziv E, Kerlikowske K, Cummings SR.

Breast Cancer Res Treat. 2017 Nov;166(2):603-612. doi: 10.1007/s10549-017-4430-2. Epub 2017 Aug 8.

20.

Emulating Bilingual Synaptic Response Using a Junction-Based Artificial Synaptic Device.

Tian H, Cao X, Xie Y, Yan X, Kostelec A, DiMarzio D, Chang C, Zhao LD, Wu W, Tice J, Cha JJ, Guo J, Wang H.

ACS Nano. 2017 Jul 25;11(7):7156-7163. doi: 10.1021/acsnano.7b03033. Epub 2017 Jun 28.

PMID:
28656774
21.

Spatial-Temporal Imaging of Anisotropic Photocarrier Dynamics in Black Phosphorus.

Liao B, Zhao H, Najafi E, Yan X, Tian H, Tice J, Minnich AJ, Wang H, Zewail AH.

Nano Lett. 2017 Jun 14;17(6):3675-3680. doi: 10.1021/acs.nanolett.7b00897. Epub 2017 May 17.

PMID:
28505461
22.

Supplemental Breast Cancer Screening: A Density Conundrum.

Tice JA, Kerlikowske K.

J Gen Intern Med. 2017 Jun;32(6):593-594. doi: 10.1007/s11606-017-3989-y. No abstract available.

23.

Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.

Shieh Y, Eklund M, Madlensky L, Sawyer SD, Thompson CK, Stover Fiscalini A, Ziv E, Van't Veer LJ, Esserman LJ, Tice JA; Athena Breast Health Network Investigators.

J Natl Cancer Inst. 2017 Jan 27;109(5). doi: 10.1093/jnci/djw290. Print 2017 Jan. Review.

PMID:
28130475
24.

Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention.

Ziv E, Tice JA, Sprague B, Vachon CM, Cummings SR, Kerlikowske K.

PLoS One. 2017 Jan 20;12(1):e0168601. doi: 10.1371/journal.pone.0168601. eCollection 2017.

25.

Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.

Kerlikowske K, Gard CC, Tice JA, Ziv E, Cummings SR, Miglioretti DL; Breast Cancer Surveillance Consortium.

J Natl Cancer Inst. 2016 Dec 31;109(5). doi: 10.1093/jnci/djw276. Print 2017 May.

26.

Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis.

Whittington MD, McQueen RB, Ollendorf DA, Tice JA, Chapman RH, Pearson SD, Campbell JD.

Ann Allergy Asthma Immunol. 2017 Feb;118(2):220-225. doi: 10.1016/j.anai.2016.10.028. Epub 2016 Dec 4.

PMID:
27923549
27.

A method for rapid sampling and characterization of smokeless powder using sorbent-coated wire mesh and direct analysis in real time - mass spectrometry (DART-MS).

Li F, Tice J, Musselman BD, Hall AB.

Sci Justice. 2016 Sep;56(5):321-328. doi: 10.1016/j.scijus.2016.06.001. Epub 2016 Jun 3.

PMID:
27702447
28.

Breast cancer risk prediction using a clinical risk model and polygenic risk score.

Shieh Y, Hu D, Ma L, Huntsman S, Gard CC, Leung JW, Tice JA, Vachon CM, Cummings SR, Kerlikowske K, Ziv E.

Breast Cancer Res Treat. 2016 Oct;159(3):513-25. doi: 10.1007/s10549-016-3953-2. Epub 2016 Aug 26.

29.

Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer Patients.

Sherman ME, Ichikawa L, Pfeiffer RM, Miglioretti DL, Kerlikowske K, Tice J, Vacek PM, Gierach GL.

PLoS One. 2016 Aug 25;11(8):e0160966. doi: 10.1371/journal.pone.0160966. eCollection 2016.

30.

Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.

Kazi DS, Moran AE, Coxson PG, Penko J, Ollendorf DA, Pearson SD, Tice JA, Guzman D, Bibbins-Domingo K.

JAMA. 2016 Aug 16;316(7):743-53. doi: 10.1001/jama.2016.11004.

PMID:
27533159
31.

A systematic review and individual patient data meta-analysis of published randomized clinical trials comparing early versus interval appendectomy for children with perforated appendicitis.

Duggan EM, Marshall AP, Weaver KL, St Peter SD, Tice J, Wang L, Choi L, Blakely ML.

Pediatr Surg Int. 2016 Jul;32(7):649-55. doi: 10.1007/s00383-016-3897-y. Epub 2016 May 9. Review.

PMID:
27161128
32.

Effectiveness and Value of Integrating Behavioral Health Into Primary Care.

Reed SJ, Shore KK, Tice JA.

JAMA Intern Med. 2016 May 1;176(5):691-2. doi: 10.1001/jamainternmed.2016.0804. Review. No abstract available.

PMID:
27064485
33.

Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B ∼ FIT Cohort.

Dallal CM, Lacey JV Jr, Pfeiffer RM, Bauer DC, Falk RT, Buist DS, Cauley JA, Hue TF, LaCroix AZ, Tice JA, Veenstra TD, Xu X, Brinton LA; B∼FIT Research Group.

Horm Cancer. 2016 Feb;7(1):49-64. doi: 10.1007/s12672-015-0237-y. Epub 2016 Jan 4.

PMID:
26728471
34.

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Treatment of High Cholesterol Levels: Effectiveness and Value.

Tice JA, Kazi DS, Pearson SD.

JAMA Intern Med. 2016 Jan;176(1):107-8. doi: 10.1001/jamainternmed.2015.7248. Review. No abstract available.

PMID:
26662572
35.

Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population.

Chahal HS, Marseille EA, Tice JA, Pearson SD, Ollendorf DA, Fox RK, Kahn JG.

JAMA Intern Med. 2016 Jan;176(1):65-73. doi: 10.1001/jamainternmed.2015.6011.

36.

Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial.

Livaudais-Toman J, Karliner LS, Tice JA, Kerlikowske K, Gregorich S, Pérez-Stable EJ, Pasick RJ, Chen A, Quinn J, Kaplan CP.

Breast. 2015 Dec;24(6):758-66. doi: 10.1016/j.breast.2015.09.009. Epub 2015 Oct 21.

37.

The effect of change in body mass index on volumetric measures of mammographic density.

Hart V, Reeves KW, Sturgeon SR, Reich NG, Sievert LL, Kerlikowske K, Ma L, Shepherd J, Tice JA, Mahmoudzadeh AP, Malkov S, Sprague BL.

Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1724-30. doi: 10.1158/1055-9965.EPI-15-0330. Epub 2015 Aug 27.

38.

Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.

Tice JA, Miglioretti DL, Li CS, Vachon CM, Gard CC, Kerlikowske K.

J Clin Oncol. 2015 Oct 1;33(28):3137-43. doi: 10.1200/JCO.2015.60.8869. Epub 2015 Aug 17.

39.

Comparative Clinical Effectiveness and Value of Novel Interferon-Free Combination Therapy for Hepatitis C Genotype 1: Summary of California Technology Assessment Forum Report.

Tice JA, Chahal HS, Ollendorf DA.

JAMA Intern Med. 2015 Sep;175(9):1559-60. doi: 10.1001/jamainternmed.2015.3348. Review. No abstract available.

PMID:
26167717
40.

Estrogen Metabolites Are Not Associated with Colorectal Cancer Risk in Postmenopausal Women.

Falk RT, Dallal CM, Lacey JV Jr, Bauer DC, Buist DS, Cauley JA, Hue TF, LaCroix AZ, Tice JA, Pfeiffer RM, Xu X, Veenstra TD, Brinton LA; B∼FIT Research Group.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1419-22. doi: 10.1158/1055-9965.EPI-15-0541. Epub 2015 Jun 23.

41.

Identifying women with dense breasts at high risk for interval cancer: a cohort study.

Kerlikowske K, Zhu W, Tosteson AN, Sprague BL, Tice JA, Lehman CD, Miglioretti DL; Breast Cancer Surveillance Consortium.

Ann Intern Med. 2015 May 19;162(10):673-81. doi: 10.7326/M14-1465.

42.

One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk.

Kerlikowske K, Gard CC, Sprague BL, Tice JA, Miglioretti DL; Breast Cancer Surveillance Consortium.

Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):889-97. doi: 10.1158/1055-9965.EPI-15-0035. Epub 2015 Mar 30.

43.

The contributions of breast density and common genetic variation to breast cancer risk.

Vachon CM, Pankratz VS, Scott CG, Haeberle L, Ziv E, Jensen MR, Brandt KR, Whaley DH, Olson JE, Heusinger K, Hack CC, Jud SM, Beckmann MW, Schulz-Wendtland R, Tice JA, Norman AD, Cunningham JM, Purrington KS, Easton DF, Sellers TA, Kerlikowske K, Fasching PA, Couch FJ.

J Natl Cancer Inst. 2015 Mar 4;107(5). pii: dju397. doi: 10.1093/jnci/dju397. Print 2015 May.

44.

Neonatal carotid repair at ECMO decannulation: patency rates and early neurologic outcomes.

Duggan EM, Maitre N, Zhai A, Krishnamoorthi H, Voskresensky I, Hardison D, Tice J, Pietsch JB, Lovvorn HN 3rd.

J Pediatr Surg. 2015 Jan;50(1):64-8. doi: 10.1016/j.jpedsurg.2014.10.029. Epub 2014 Dec 7.

45.

"Arthroscopic washout of the knee: a procedure in decline" by Stefan Lazic et al.

Tice JW.

Knee. 2014 Dec;21(6):1300. doi: 10.1016/j.knee.2014.11.009. No abstract available.

PMID:
25498424
46.

Changes in breast cancer risk distribution among Vermont women using screening mammography.

Bolton KC, Mace JL, Vacek PM, Herschorn SD, James TA, Tice JA, Kerlikowske K, Geller BM, Weaver DL, Sprague BL.

J Natl Cancer Inst. 2014 Jun 23;106(8). pii: dju157. doi: 10.1093/jnci/dju157. Print 2014 Aug.

47.

The comparative clinical effectiveness and value of simeprevir and sofosbuvir for chronic hepatitis C virus infection.

Ollendorf DA, Tice JA, Pearson SD.

JAMA Intern Med. 2014 Jul;174(7):1170-1. doi: 10.1001/jamainternmed.2014.2151. Review. No abstract available.

PMID:
24798321
48.

A randomized, controlled trial to increase discussion of breast cancer in primary care.

Kaplan CP, Livaudais-Toman J, Tice JA, Kerlikowske K, Gregorich SE, Pérez-Stable EJ, Pasick RJ, Chen A, Quinn J, Karliner LS.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1245-53. doi: 10.1158/1055-9965.EPI-13-1380. Epub 2014 Apr 24.

49.

Perceived versus objective breast cancer risk in diverse women.

Fehniger J, Livaudais-Toman J, Karliner L, Kerlikowske K, Tice JA, Quinn J, Ozanne E, Kaplan CP.

J Womens Health (Larchmt). 2014 May;23(5):420-7. doi: 10.1089/jwh.2013.4516. Epub 2013 Dec 28.

50.

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: summary assessment of the California Technology Assessment Forum.

Tice JA, Sellke FW, Schaff HV.

J Thorac Cardiovasc Surg. 2014 Aug;148(2):482-91.e6. doi: 10.1016/j.jtcvs.2013.09.056. Epub 2013 Nov 16. Review.

Supplemental Content

Support Center